Bienville Capital Management, LLC Abbott Laboratories Transaction History

Bienville Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $213,063 - $258,749	-2,325 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $178,025 - $227,850	2,325 New	2,325 $213,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $420,821 - $456,301	-5,142 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $437 - $510	6 Added 0.12%	5,142 $432,000
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $9,601 - $11,608	-145 Reduced 2.75%	5,136 $411,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $346,222 - $392,219	5,281 New	5,281 $382,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $264,919 - $299,522	-4,708 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $29,094 - $31,148	-542 Reduced 10.32%	4,708 $269,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $252,315 - $281,610	5,250	5,250 $280,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bienville Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bienville Capital Management, LLC with notifications on news.